<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Philos Trans R Soc Lond B Biol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Philos. Trans. R. Soc. Lond., B, Biol. Sci</journal-id>
<journal-id journal-id-type="publisher-id">RSTB</journal-id>
<journal-id journal-id-type="hwp">royptb</journal-id>
<journal-title-group>
<journal-title>Philosophical Transactions of the Royal Society B: Biological Sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">0962-8436</issn>
<issn pub-type="epub">1471-2970</issn>
<publisher>
<publisher-name>The Royal Society</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26416679</article-id>
<article-id pub-id-type="pmc">4633997</article-id>
<article-id pub-id-type="doi">10.1098/rstb.2014.0368</article-id>
<article-id pub-id-type="publisher-id">rstb20140368</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>1001</subject>
<subject>133</subject>
<subject>33</subject>
<subject>31</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
<subj-group subj-group-type="leader">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Direct somatic lineage conversion</article-title>
<alt-title alt-title-type="short">Direct somatic lineage conversion</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tanabe</surname>
<given-names>Koji</given-names>
</name>
<xref ref-type="author-notes" rid="AN1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Haag</surname>
<given-names>Daniel</given-names>
</name>
<xref ref-type="author-notes" rid="AN1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wernig</surname>
<given-names>Marius</given-names>
</name>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
</contrib-group>
<aff><addr-line>Institute for Stem Cell Biology and Regenerative Medicine and Department of Pathology</addr-line>, <institution>Stanford University School of Medicine</institution>, <addr-line>Stanford, CA 94305</addr-line>, <country>USA</country></aff>
<author-notes>
<corresp id="cor1">e-mail: <email>wernig@stanford.edu</email></corresp>
<fn fn-type="con" id="AN1">
<label>†</label>
<p>These authors contributed equally to this study.</p>
</fn>
<fn fn-type="other">
<p>One contribution of 13 to a discussion meeting issue ‘<ext-link ext-link-type="uri" xlink:href="http://rstb.royalsocietypublishing.org/content/370/1680.toc">Cells: from Robert Hooke to cell therapy—a 350 year journey</ext-link>’.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>19</day>
<month>10</month>
<year>2015</year>
</pub-date>
<volume>370</volume>
<issue>1680</issue>
<issue-title>Discussion meeting issue ‘Cells: from Robert Hooke to cell therapy—a 350 year journey’ organized and edited by Johan Hyllner, Chris Mason and Ian Wilmut</issue-title>
<elocation-id>20140368</elocation-id>
<history>
<date date-type="accepted">
<day>31</day>
<month>7</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© 2015 The Author(s)</copyright-statement>
<copyright-year>2015</copyright-year>
<license specific-use="vor" xlink:href="http://royalsocietypublishing.org/licence">
<license-p>Published by the Royal Society. All rights reserved.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="rstb20140368.pdf"></self-uri>
<abstract>
<p>The predominant view of embryonic development and cell differentiation has been that rigid and even irreversible epigenetic marks are laid down along the path of cell specialization ensuring the proper silencing of unrelated lineage programmes. This model made the prediction that specialized cell types are stable and cannot be redirected into other lineages. Accordingly, early attempts to change the identity of somatic cells had little success and was limited to conversions between closely related cell types. Nuclear transplantation experiments demonstrated, however, that specialized cells even from adult mammals can be reprogrammed into a totipotent state. The discovery that a small combination of transcription factors can reprogramme cells to pluripotency without the need of oocytes further supported the view that these epigenetic barriers can be overcome much easier than assumed, but the extent of this flexibility was still unclear. When we showed that a differentiated mesodermal cell can be directly converted to a differentiated ectodermal cell without a pluripotent intermediate, it was suggested that in principle any cell type could be converted into any other cell type. Indeed, the work of several groups in recent years has provided many more examples of direct somatic lineage conversions. Today, the question is not anymore whether a specific cell type can be generated by direct reprogramming but how it can be induced.</p>
</abstract>
<kwd-group>
<kwd>cell fate conversion</kwd>
<kwd>direct reprogramming</kwd>
<kwd>induced neuronal cells</kwd>
<kwd>induced pluripotent stem cells</kwd>
<kwd>pluripotent stem cell-derived induced neuronal cells</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>October 19, 2015</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>